Literature DB >> 404244

Exotoxin production by clinical isolates of pseudomonas aeruginosa.

M Pollack, N S Taylor, L T Callahan.   

Abstract

Seventy-five consecutive clinical Pseudomonas aeruginosa isolates were tested for in vitro exotoxin production. Exotoxin was demonstrated in culture filtrates biologically, by its ability to produce characteristic dermonecrotic lesions in guinea pigs, and seriologically, by counterimmunoelectrophoresis (CIE) with rabbit antiserum elicited with purified exotoxin. By these two methods, exotoxin was detected in 87 and 89% of P. aeruginosa strains, respectively (r = 0.48, P less than 0.001). Although less sensitive than CIE in detecting exotoxin immunodiffusion demonstrated a reaction of antigenic identity in most cases. Exotoxin was produced by all seven Fisher-Devlin immunotypes and by untypable strains. In contrast, exotoxin was not detected in the culture filtrates of 16 non-aeruginosa pseudomonas isolates and 48 non-pseudomonas organisms. The production of biologically similar antigenically closely related exotoxins is thus a characteristic of the majority of P. aeruginosa strains derived from diverse clinical sources.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404244      PMCID: PMC421439          DOI: 10.1128/iai.15.3.776-780.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  THE LOWRY MODIFICATION OF THE FOLIN REAGENT FOR DETERMINATION OF PROTEINASE ACTIVITY.

Authors:  C E MCDONALD; L L CHEN
Journal:  Anal Biochem       Date:  1965-01       Impact factor: 3.365

2.  Pseudomonas exotoxin shock. A preliminary report of studies in dogs.

Authors:  M Atik; P V Liu; B A Hanson; S Amini; C F Rosenberg
Journal:  JAMA       Date:  1968-07-15       Impact factor: 56.272

3.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

4.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

5.  Exotoxins of Pseudomonas aeruginosa. II. Concentration, purification, and characterization of exotoxin A.

Authors:  P V Liu; S Yoshii; H Hsieh
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

6.  Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.

Authors:  P V Liu; H Hsieh
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

7.  Pseudomonas aeruginosa in a center for cancer research. I. Distribution of intraspecies types from human and environmental sources.

Authors:  M R Moody; V M Young; D M Kenton; G D Vermeulen
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

8.  Pseudomonas aeruginosa exotoxin: effect on cell cultures.

Authors:  O R Pavlovskis; F B Gordon
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

9.  Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae.

Authors:  J A Washington; P K Yu; W J Martin
Journal:  Appl Microbiol       Date:  1971-09

10.  Pseudomonas aeruginosa exotoxin in mice: localization and effect on protein synthesis.

Authors:  O R Pavlovskis; A H Shackelford
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

View more
  34 in total

1.  [Use of pseudomonas immunoglobulin in ventilated patients at an interdisciplinary surgical intensive care station].

Authors:  I Class; W Junginger; T Klöss
Journal:  Infection       Date:  1987       Impact factor: 3.553

2.  Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.

Authors:  B H Iglewski; J Sadoff; M J Bjorn; E S Maxwell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.

Authors:  N S Taylor; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA-103.

Authors:  M J Bjorn; B H Iglewski; S K Ives; J C Sadoff; M L Vasil
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

5.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

6.  Proteinases produced by pseudomonads isolated from sheep fleece.

Authors:  C J London; I P Griffith; A A Kortt
Journal:  Appl Environ Microbiol       Date:  1984-01       Impact factor: 4.792

7.  [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].

Authors:  M S Collins; R F Hector; R E Roby; A A Edwards; D K Ladehoff; J H Dorsey
Journal:  Infection       Date:  1987       Impact factor: 3.553

8.  Production of leukocidin by clinical isolates of Pseudomonas aeruginosa and antileukocidin antibody from sera of patients with diffuse panbronchiolitis.

Authors:  J Y Homma; M Matsuura; M Shibata; Y Kazuyama; M Yamamoto; Y Kubota; T Hirayama; I Kato
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

9.  Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia.

Authors:  G B Stover; D R Drake; T C Montie
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.

Authors:  M Pollack; N S Taylor
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.